stachybosins (Asahi)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namestachybosins (Asahi)
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsHypertensionCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsahi Kasei Pharma Corp
Active IndicationsN/A
Inactive IndicationsHypertensionCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A